Phil Jackson continues to plan for the summer of 2015.
According to Marc Berman, of the New York Post, Jackson and the New York Knicks could be interested in disgruntled big man Andrew Bynum. The former connection between Jackson and Bynum’s time with the Lakers between 2006-11 could be the driving factor in the Knicks’ interest.
It also doesn’t hurt the fact that the Knicks will desperately be in need of a big man after the season when the contracts of Samuel Dalembert, Amar’e Stoudemire, Andrea Bargnani and Jason Smith come off the books.
But before the Knicks, or any other team for that matter, show sincere interest in Bynum, he needs to get healthy. And that’s what the 26-year-old center is hoping to do this offseason.
The 7-foot Bynum may not be reuniting with Phil Jackson’s Knicks or any other team next season because he is seriously contemplating sitting out 2014-15 to undergo the Germany-based knee therapy called “The Regenokine Program’’ that would require an extra long rehab, according to his agent David Lee. But he could be in play for the following season.
Regenokine is a non-surgical program that promotes new cartilage growth through a series of injections. The FDA still hasn’t approved it in the United States. Bynum is considering doing the program with well-known doctor German doctor Peter Wehling, who worked with Kobe Bryant and Alex Rodriguez. It is similar but not identical to the PRP procedure.
The Knicks pursued Bynum last February before Jackson came aboard, but he signed with the Pacers, though he couldn’t remain healthy. He played 26 games last season: 24 with Cleveland before being waived for disciplinary reasons and two with the Pacers.
“If he’s healthy, Phil will be interested,’’ Lee told The Post. “Phil knew how to tap into Andrew. They got along famously.’’
Bynum played his best season of his career with the Lakers in 2012, where he averaged 18.7 points 11.8 rebounds per game in 60 games played. Bynum played a limited role with the Cleveland Cavaliers and the Indiana Pacers last season.